Effectiveness of high-frequency repetitive transcranial magnetic stimulation in patients with depression and Parkinson’s disease: a meta-analysis of randomized, controlled clinical trials

References

• RaoSSHofmannLAShakilAParkinson’s disease: diagnosis and treatmentAm Fam Physician2006742046205417186710
   PubMed Web of Science ®Google Scholar
• OlanowCWSternMBSethiKThe scientific and clinical basis for the treatment of Parkinson disease (2009)Neurology200972S1S136
   PubMed Web of Science ®Google Scholar
• HsuHYHuangTTWengYHThe inclination to depressive mood and related factors among patients with Parkinson’s diseaseJournal of Evidence-Based Nursing20073195204 Available from: http://www.airitilibrary.com/Publication/alDetailedMesh?DocID=18142869-200709-3-3-195-204-aAccessed December 14, 2017
   Google Scholar
• TagliatiMChaudhuriKPaganoGPrevalence of non-motor symptoms in Parkinson’s disease: A systematic review with meta-analysis (P2.053)Neurology20148210 Supple
   Google Scholar
• DissanayakaNNSellbachASilburnPAO’SullivanJDMarshRMellickGDFactors associated with depression in Parkinson’s diseaseJ Affect Disord2011132828821356559
   PubMed Web of Science ®Google Scholar
• PachanaNAEganSJLaidlawKClinical issues in the treatment of anxiety and depression in older adults with Parkinson’s diseaseMov Disord2013281930193424123116
   PubMed Web of Science ®Google Scholar
• WuPLLeeMHuangTTEffectiveness of physical activity on patients with depression and Parkinson’s disease: A systematic reviewPLoS One201712e018151528749970
   PubMed Web of Science ®Google Scholar
• SchragAJahanshahiMQuinnNWhat contributes to quality of life in patients with Parkinson’s disease?J Neurol Neurosurg Psychiatry20006930831210945804
   PubMed Web of Science ®Google Scholar
• Bomasang-LaynoEFadlonIMurrayANHimelhochSAntidepressive treatments for Parkinson’s disease: a systematic review and meta-analysisParkinsonism Relat Disord20152183384226037457
   PubMed Web of Science ®Google Scholar
• XieCLChenJWangXDRepetitive transcranial magnetic stimulation (rTMS) for the treatment of depression in Parkinson disease: a meta-analysis of randomized controlled clinical trialsNeurol Sci2015361751176126209930
   PubMed Web of Science ®Google Scholar
• Wagle ShuklaAVaillancourtDETreatment and physiology in Parkinson’s disease and dystonia: using transcranial magnetic stimulation to uncover the mechanisms of actionCurr Neurol Neurosci Rep20141444924771105
   PubMed Web of Science ®Google Scholar
• GeorgeMSLisanbySHAveryDDaily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trialArch Gen Psychiatry20106750751620439832
   PubMed Web of Science ®Google Scholar
• O’ReardonJPSolvasonHBJanicakPGEfficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: A multisite randomized controlled trialBiol Psychiatry2007621208121617573044
   PubMed Web of Science ®Google Scholar
• LefaucheurJPAndre-ObadiaNAntalAEvidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS)Clin Neurophysiol20141252150220625034472
   PubMed Web of Science ®Google Scholar
• BerlimMTvan den EyndeFTovar-PerdomoSDaskalakisZJResponse, remission and drop-out rates following high-frequency repetitive transcranial magnetic stimulation (rTMS) for treating major depression: a systematic review and meta-analysis of randomized, double-blind and sham-controlled trialsPsychol Med20144422523923507264
   PubMed Web of Science ®Google Scholar
• KedziorKKAzorinaVReitzSKMore female patients and fewer stimuli per session are associated with the short-term antidepressant properties of repetitive transcranial magnetic stimulation (rTMS): a meta-analysis of 54 sham-controlled studies published between 1997–2013Neuropsychiatr Dis Treat20141072775624855360
   PubMed Web of Science ®Google Scholar
• DowdSRadoJWelchMJTranscranial magnetic stimulation for depressionCurr Psychiatry200872735 Available from: https://www.mdedge.com/sites/default/files/Document/September-2017/0712CP_Pipeline.pdfAccessed December 22, 2017
   Google Scholar
• FengJMLiSMGuoWResearch of optimize rTMS treatment for depression in Parkinson’s diseaseHaiNan Med2012233538 Chinese. Available from: http://www.hainanyixue.cn/zadmin/aupload-file/zzspdf/20122316/20122316-13.pdfAccessed December 22, 2017
   Google Scholar
• NiuXPGouYCObservation of rTMS treatment for depression in Parkinson’s diseaseChin J Prac Nerv Dis2012151113 Chinese. Available from: http://hnsj.cbpt.cnki.net/WKE/WebPublication/paper-Digest.aspx?paperID=8dea936c-0b7b-49d0-b92d-1a3f65d05fb0#Accessed December 22, 2017
   Google Scholar
• WuZHCenHHCuiLQEfficacy studies of high and low frequency repetitive transcranial magnetic stimulation joint sertraline in the treatment of Parkinson’s disease patients with depressionMod Diagn Treat20132421642167 Available from: http://en.cnki.com.cn/Article_en/CJFDTOTAL-XDZD201310005.htmAccessed December 22, 2017
   Google Scholar
• SkapinakisPBakolaESalantiGLewisGKyritsisAPMavreasVEfficacy and acceptability of selective serotonin reuptake inhibitors for the treatment of depression in Parkinson’s disease: a systematic review and meta-analysis of randomized controlled trialsBMC Neurol2010104920565960
   PubMed Web of Science ®Google Scholar
• PalENagyFAschermannZBalazsEKovacsNThe impact of left prefrontal repetitive transcranial magnetic stimulation on depression in Parkinson’s disease: a randomized, double-blind, placebo-controlled studyMov Disord2010252311231720740485
   PubMed Web of Science ®Google Scholar
• BrysMFoxMDAgarwalSMultifocal repetitive TMS for motor and mood symptoms of Parkinson disease: A randomized trialNeurology2016871907191527708129
   PubMed Web of Science ®Google Scholar
• ShinHWYounYCChungSJEffect of high-frequency repetitive transcranial magnetic stimulation on major depressive disorder in patients with Parkinson’s diseaseJ Neurol20162631442144827178002
   PubMed Web of Science ®Google Scholar
• MakkosAPálEAschermannZHigh-frequency repetitive transcranial magnetic stimulation can improve depression in Parkinson’s disease: A randomized, double-blind, placebo-controlled studyNeuropsychobiology20167316917727093063
   PubMed Web of Science ®Google Scholar
• HigginsJPTGreenSCochrane Collaboration Cochrane Handbook for Systematic Reviews of InterventionsChichester, UK; Hoboken, NJWiley-Blackwell2008
   Google Scholar
• MoherDLiberatiATetzlaffJAltmanDGPRISMA groupPreferred reporting items for systematic reviews and meta-analyses: the PRISMA statementBMJ2009339b253519622551
   PubMed Web of Science ®Google Scholar
• HughesAJDanielSEKilfordLLeesAJAccuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinicopathological study of 100 casesJ Neurol Neurosurg Psychiatry1992551811841564476
   PubMed Web of Science ®Google Scholar
• HamiltonMA rating scale for depressionJ Neurol Neurosurg Psychiatry196023566214399272
   PubMed Web of Science ®Google Scholar
• MontgomerySAÅsbergMA new depression scale designed to be sensitive to changeBr J Psychiatry1979134382389444788
   PubMed Web of Science ®Google Scholar
• BeckATWardCMendelsonMMockJErbaughJAn inventory for measuring depressionArch Gen Psychiatry1961456157113688369
   PubMed Web of Science ®Google Scholar
• FahnSEltonRLUPDRS program membersUnified Parkinson’s Disease Rating ScaleFlorham Park, NJMacmillan Healthcare Information1987
   Google Scholar
• HigginsJPThompsonSGQuantifying heterogeneity in a meta-analysisStat Med2002211539155812111919
   PubMed Web of Science ®Google Scholar
• BoggioPSFregniFBermpohlFEffect of repetitive TMS and fluoxetine on cognitive function in patients with Parkinson’s disease and concurrent depressionMov Disord2005201178118415895421
   PubMed Web of Science ®Google Scholar
• CardosoEFFregniFMartins MaiaFrTMS treatment for depression in Parkinson’s disease increases BOLD responses in the left prefrontal cortexInt J Neuropsychopharmacol20081117318317708780
   PubMed Web of Science ®Google Scholar
• ChenSDYuSWZhaoJFThe effect of rTMS treatment for depression in Parkinson’s diseaseChin J Gerontol20113134823484 Chinese. Available from: http://kns.cnki.net/KCMS/detail/detail.aspx?dbcode=CJFQ&dbname=CJFD2011&filename=ZLXZ2011180-21&v=MTUzMjIxTHV4WVM3RGgxVDNxVHJXTTFGckNVUkwyZVplUm5GQ25oVzczQVB5SFRkTEc0SDlETnA0OUhaWVI4ZVg=Accessed December 22, 2017
   Google Scholar
• FregniFSantosCMMyczkowskiMLRepetitive transcranial magnetic stimulation is as effective as fluoxetine in the treatment of depression in patients with Parkinson’s diseaseJ Neurol Neurosurg Psychiatry2004751171117415258224
   PubMed Web of Science ®Google Scholar
• TarhanNSayarFGTanOKaganGEfficacy of high-frequency repetitive transcranial magnetic stimulation in treatment-resistant depressionClin EEG Neurosci20124327928423185087
   PubMed Web of Science ®Google Scholar
• EcheJMondinoMHaesebaertFSaoudMPouletEBrunelinJLow- vs. high-frequency repetitive transcranial magnetic stimulation as an add-on treatment for refractory depressionFront Psychiatry201231322408627
   PubMedGoogle Scholar
• FitzgeraldPBFountainSDaskalakisZJA comprehensive review of the effects of rTMS on motor cortical excitability and inhibitionClin Neurophysiol20061172584259616890483
   PubMed Web of Science ®Google Scholar
• KhedrEMRothwellJCShawkyOAAhmedMAHamdyAEffect of daily repetitive transcranial magnetic stimulation on motor performance in Parkinson’s diseaseMov Disord2006212201220517219616
   PubMed Web of Science ®Google Scholar
• LomarevMPKanchanaSBara-JimenezWIyerMWassermannEMHallettMPlacebo-controlled study of rTMS for the treatment of Parkinson’s diseaseMov Disord20062132533116211618
   PubMed Web of Science ®Google Scholar
• ElahiBElahiBChenREffect of transcranial magnetic stimulation on Parkinson motor function – systematic review of controlled clinical trialsMov Disord20092435736318972549
   PubMed Web of Science ®Google Scholar
• ZhuoCXueRLuoLEfficacy of antidepressive medication for depression in Parkinson disease: a network meta-analysisMedicine (Baltimore)201796e669828562526
   PubMed Web of Science ®Google Scholar
• WassermannEMZimmermannTTranscranial magnetic brain stimulation: therapeutic promises and scientific gapsPharmacol Ther20121339810721924290
   PubMed Web of Science ®Google Scholar